Lombartaes et al. observed that CDH1 promoter hypermethylation, but not CDH1 mutational inactivation, in the context of the EMT, resulted in a more aggressive tumor cell phenotype, and increased invasiveness [20]. The gene discussed is CDH1; the disease is neoplasm.